Your browser doesn't support javascript.
loading
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau, Kevin; Abe, Kento T; Naimark, David; Oliver, Matthew J; Perl, Jeffrey; Leis, Jerome A; Bolotin, Shelly; Tran, Vanessa; Mullin, Sarah I; Shadowitz, Ellen; Gonzalez, Anny; Sukovic, Tatjana; Garnham-Takaoka, Julie; de Launay, Keelia Quinn; Takaoka, Alyson; Straus, Sharon E; McGeer, Allison J; Chan, Christopher T; Colwill, Karen; Gingras, Anne-Claude; Hladunewich, Michelle A.
Afiliação
  • Yau K; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Abe KT; Division of Nephrology, Department of Medicine, Unity Health Toronto, Toronto, Ontario, Canada.
  • Naimark D; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Oliver MJ; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
  • Perl J; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Leis JA; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Bolotin S; Division of Nephrology, Department of Medicine, Unity Health Toronto, Toronto, Ontario, Canada.
  • Tran V; Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
  • Mullin SI; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Shadowitz E; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Gonzalez A; Public Health Ontario, Toronto, Ontario, Canada.
  • Sukovic T; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Garnham-Takaoka J; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • de Launay KQ; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Takaoka A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Straus SE; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • McGeer AJ; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Chan CT; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Colwill K; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Gingras AC; Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
  • Hladunewich MA; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
JAMA Netw Open ; 4(9): e2123622, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34473256

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos